Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels
Biological and Pharmaceutical Bulletin · 01.08.2023 · 46 (8) · 1041-1048
DOI: 10.1248/bpb.b22-00796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 01.08.2023. Verfasst von Liangliang Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Isoflavones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Thyroid cancer (TC) is the most common malignant tumor of endocrine system and head and neck. Ononin is an isoflavone component, which exhibited great antioxidant and anti-inflammatory activities. This study was conducted to explore the functions of ononin in the TC progression. The cell counting kit-8 (CCK8) assay was applied for the cell viability determination. The cell death and apoptosis rate were analyzed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining and flow cytometry. The quantitative real-time PCR (qRT-PCR) and Western blot assays were performed for the relative expressions determination. Lactate dehydrogenase (LDH) release assay was used to assess cytotoxicity. Ononin treatment prominently inhibited the cell viability and induced the cell apoptosis of the TC cells. Besides, caspase 3 (CASP3) was down-regulated and CD274 was up-regulated in TC. Ononin treatment prominently decreased the CD274 levels and increased the CASP3 levels in the TC cells. Additionally, ononin treatment dramatically enhanced the LDH release of the cytotoxicity of T cells. What is more, CASP3 overexpression or CD274 knockdown promoted the role of ononin in TC cells. Ononin treatment induced the cell death of the TC cells through regulating the CASP3 and CD274 expressions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine.
Zitieren
APA
Du, L., Zeng, D., Hu, X., Ren, X., & He, D. (2023). Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels. Biological and Pharmaceutical Bulletin, 46(8), 1041-1048. https://doi.org/10.1248/bpb.b22-00796
Vancouver
Du L, Zeng D, Hu X, Ren X, He D. Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels. Biological and Pharmaceutical Bulletin. 2023;46(8):1041-1048. doi:10.1248/bpb.b22-00796
BibTeX
@article{Du2023,
author = {Du, Liangliang and Zeng, Douyun and Hu, Xian and Ren, Xi and He, Dazhi},
title = {Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
volume = {46},
number = {8},
pages = {1041--1048},
doi = {10.1248/bpb.b22-00796}
}
EUVIMED